Prognostic Value of Somatostatin Receptor Scintigraphy on High-Grade Neuroendocrine Neoplasms and Impact on the Treatment Decision of Intermediate-Grade Neuroendocrine Neoplasms

被引：0
|
作者：
Jia, R. [1 ]
Fu, Y. L. [1 ]
Lin, L. [1 ]
Wang, Y. [1 ]
Ge, F. J. [1 ]
Zhao, C. H. [1 ]
Li, Z. Q. [1 ]
Chen, Y. L. [1 ]
Liu, L. J. [1 ]
Liu, J. Z. [1 ]
Xu, J. M. [1 ]
机构：
[1] 307 Hosp PLA, Beijing, Peoples R China
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
neuroendocrine; srs; prognosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E6
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [31] Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
    Sorbye, H.
    Venizelos, A.
    Perren, A.
    Couvelard, A.
    Hjortland, G. O.
    Sundlov, A.
    Svensson, J.
    Garresori, H.
    Vestermark, L. W.
    Tabaksblat, E.
    Elvebakken, H.
    Knappskog, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 35 - 35
  • [32] Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms
    Que, Qing-Yang
    Zhang, Lin-Cheng
    Bao, Jia-Qi
    Ling, Sun-Bin
    Xu, Xiao
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 14 (05): : 397 - 408
  • [33] Challenges in the Classification of High-Grade Neuroendocrine Neoplasms Based on Current Recommendations
    Joseph, Nancy
    Kim, Grace
    Umetsu, Sarah
    Kakar, Sanjay
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1046 - 1046
  • [34] High-grade neuroendocrine neoplasms of the pancreas:A case report and literature review
    He, Zifan
    Zhou, Yang
    Zhou, Feilong
    ASIAN JOURNAL OF SURGERY, 2024, 47 (05) : 2370 - 2372
  • [35] The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond
    Sorbye, Halfdan
    Baudin, Eric
    Perren, Aurel
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (03) : 683 - +
  • [36] P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
    Kirstine Nielsen
    Tina Binderup
    Seppo W. Langer
    Andreas Kjaer
    Pauline Knigge
    Veronica Grøndahl
    Linea Melchior
    Birgitte Federspiel
    Ulrich Knigge
    BMC Cancer, 20
  • [37] P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
    Nielsen, Kirstine
    Binderup, Tina
    Langer, Seppo W.
    Kjaer, Andreas
    Knigge, Pauline
    Grondahl, Veronica
    Melchior, Linea
    Federspiel, Birgitte
    Knigge, Ulrich
    BMC CANCER, 2020, 20 (01)
  • [38] Clinicopathological Features of the High Grade Pancreatic Neuroendocrine Neoplasms
    Delektorskaya, V
    Solovieva, O.
    Koslov, N.
    Patyutko, Y.
    NEUROENDOCRINOLOGY, 2018, 106 : 139 - 139
  • [39] Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms
    Pommergaard, Hans-Christian
    Nielsen, Kirstine
    Sorbye, Halfdan
    Federspiel, Birgitte
    Tabaksblat, Elizaveta M.
    Vestermark, Lene W.
    Janson, Eva T.
    Hansen, Carsten P.
    Ladekarl, Morten
    Garresori, Herish
    Hjortland, Geir O.
    Sundlov, Anna
    Galleberg, Renate
    Knigge, Pauline
    Kjaer, Andreas
    Langer, Seppo W.
    Knigge, Ulrich
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 (05)
  • [40] Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms
    MacFarlane, Alexander W.
    Yeung, Ho-Man
    Alpaugh, R. Katherine
    Dulaimi, Essel
    Engstrom, Paul F.
    Dasari, Arvind
    Campbell, Kerry S.
    Vijayvergia, Namrata
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1893 - 1906
12345